Overview
Jeffrey Szer practices in Parkville, Australia. Szer is rated as an Elite expert by MediFind in the treatment of Paroxysmal Cold Hemoglobinuria. Their top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Hemolysis, Hemolytic Anemia, and Bone Marrow Transplant.
Their clinical research consists of co-authoring 47 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Paroxysmal Cold Hemoglobinuria.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Paroxysmal Cold Hemoglobinuria
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Distinguished
- AnemiaSzer isDistinguished. Learn about Anemia.
- HemolysisSzer isDistinguished. Learn about Hemolysis.
- Hemolytic AnemiaSzer isDistinguished. Learn about Hemolytic Anemia.
- Advanced
- Aplastic AnemiaSzer isAdvanced. Learn about Aplastic Anemia.
- Bone Marrow Transplant
- Gaucher DiseaseSzer isAdvanced. Learn about Gaucher Disease.
- Gaucher Disease Type 1
- Experienced
- Acute Myeloid Leukemia (AML)
- Blood ClotsSzer isExperienced. Learn about Blood Clots.
- Chronic Myelogenous Leukemia (CML)
- Farber LipogranulomatosisSzer isExperienced. Learn about Farber Lipogranulomatosis.
- Graft Versus Host Disease (GvHD)
- Hodgkin LymphomaSzer isExperienced. Learn about Hodgkin Lymphoma.